These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8825412)

  • 21. Inhibition of cell death by lens-specific overexpression of bcl-2 in transgenic mice.
    Fromm L; Overbeek PA
    Dev Genet; 1997; 20(3):276-87. PubMed ID: 9216067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
    Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
    J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.
    D'Sa-Eipper C; Chinnadurai G
    Oncogene; 1998 Jun; 16(24):3105-14. PubMed ID: 9671389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-XL protects cancer cells from p53-mediated apoptosis.
    Schott AF; Apel IJ; Nuñez G; Clarke MF
    Oncogene; 1995 Oct; 11(7):1389-94. PubMed ID: 7478561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCL-2 proteins and apoptosis: Recent insights and unknowns.
    Edlich F
    Biochem Biophys Res Commun; 2018 May; 500(1):26-34. PubMed ID: 28676391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions.
    Falleni M; Pellegrini C; Marchetti A; Roncalli M; Nosotti M; Palleschi A; Santambrogio L; Coggi G; Bosari S
    Lung Cancer; 2005 May; 48(2):211-6. PubMed ID: 15829320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2015 Mar; 94(1):1-11. PubMed ID: 25562745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. bcl-2 in cancer, development and apoptosis.
    Hockenbery DM
    J Cell Sci Suppl; 1994; 18():51-5. PubMed ID: 7883792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCL-2 gene family and the regulation of programmed cell death.
    Korsmeyer SJ
    Cancer Res; 1999 Apr; 59(7 Suppl):1693s-1700s. PubMed ID: 10197582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
    Eliopoulos AG; Kerr DJ; Herod J; Hodgkins L; Krajewski S; Reed JC; Young LS
    Oncogene; 1995 Oct; 11(7):1217-28. PubMed ID: 7478541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review].
    Merino JJ; Cordero-Campaña MI
    Invest Clin; 1998 Dec; 39(4):323-58. PubMed ID: 9927805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
    Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis and cancer chemotherapy.
    Chresta CM; Arriola EL; Hickman JA
    Behring Inst Mitt; 1996 Oct; (97):232-40. PubMed ID: 8950479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary.
    Kugu K; Ratts VS; Piquette GN; Tilly KI; Tao XJ; Martimbeau S; Aberdeen GW; Krajewski S; Reed JC; Pepe GJ; Albrecht ED; Tilly JL
    Cell Death Differ; 1998 Jan; 5(1):67-76. PubMed ID: 10200447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
    Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
    Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer.
    Shore GC; Viallet J
    Hematology Am Soc Hematol Educ Program; 2005; ():226-30. PubMed ID: 16304385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.